April 3rd 2025
Radenkovic is a PhD candidate at KU Leuven and a member of FeMS. Her research focuses on inborn metabolic disorders (IMD), like congenital disorders of glycosylation (CDG), omics techniques such as tracer metabolomics, and different disease models.
Comprehensive Analysis Unveils Chemical Composition of Lingbao Huxin Dan for Cardiovascular Health
February 7th 2024Researchers employed advanced chromatography and mass spectrometry techniques to unravel the chemical components and metabolites of Lingbao Huxin Dan, pinpointing its therapeutic potential for cardiovascular ailments.
Scientists Reveal New Method for Soil Pesticide Detection Based on UHPLC-MS/MS
February 1st 2024Scientists in Mexico developed a new method for detecting herbicides in agricultural soil, being based on techniques like 9-fluorenylmethyl chloroformate (FMOC-Cl) and ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).
Q&A: Unraveling the Dynamics of GM3 Gangliosides in Human Milk Across Lactation Stages
February 1st 2024Weronika Hewelt-Belka, an assistant professor at Gdańsk University of Technology in Poland, answers questions about her research analyzing GM3 gangliosides in human milk, elucidating their molecular distribution and dynamic changes throughout lactation.
Inside the Laboratory: The Yang Group of the University of Oklahoma
January 16th 2024In our second edition of “Inside the Laboratory,” Zhibo Yang, PhD, an associate professor of chemistry at the University of Oklahoma, discusses his group’s most recent work in single-cell mass spectrometry (MS) and MS tissue imaging.
Synthesizing Synthetic Oligonucleotides: An Interview with the CEO of Oligo Factory
January 15th 2024LCGC and Spectroscopy Editor Patrick Lavery spoke with Oligo Factory CEO Chris Boggess about the company’s recently attained compliance with Good Manufacturing Practice (GMP) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Expert Working Group (Q7) guidance and its distinction from Research Use Only (RUO) and International Organization for Standardization (ISO) 13485 designations.
This review article discusses scientific rationales and current best practices in the pharmaceutical industry for performing chromatographic peak purity assessments (PPA). These activities are associated with the development and validation of liquid chromatographic (LC) stability-indicating analytical methods applicable to regulatory submissions of small-molecule drug candidates. The discussion includes a comprehensive overview of the PPA-related regulatory and scientific landscape and common industry approaches to obtain PPA results, as well as the strengths and weaknesses of PDA-facilitated ultraviolet (UV) PPA and other PPA techniques.
Flow-Injection MS Selectively Ionizes Oxidized Triacylglycerols Versus Non-Oxidized Precursors
December 15th 2023While lipid oxidation in food is a serious problem, lipid species in both oxidized and non-oxidized forms at varying concentrations make detection and identification of the less abundant species difficult.